EcoDrugPlus

Toll-Like Receptor 8

Ensembl ID : ENSAMXG00000025614
Gene Symbol: LOC103023350
2 Cross references
184 Possible Orthologues:

Trace Amine Associated Receptor 1b

Ensembl ID : ENSAMXG00000026314
Gene Symbol: TAAR1B
1 Cross references
149 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSAMXG00000000475
Gene Symbol: TRPA1
3 Cross references
201 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1-Like

Ensembl ID : ENSAMXG00000008417
Gene Symbol: LOC103022174
3 Cross references
158 Possible Orthologues:

Transthyretin (Prealbumin, Amyloidosis Type I)

Ensembl ID : ENSAMXG00000002423
Gene Symbol: TTR
1 Cross references
180 Possible Orthologues:

Tryptophan 5-Hydroxylase 1-Like

Ensembl ID : ENSAMXG00000037098
Gene Symbol: LOC103025693
3 Cross references
177 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSAMXG00000018104
Gene Symbol: TPH1
3 Cross references
214 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSAMXG00000030467
Gene Symbol: LOC103042625
3 Cross references
155 Possible Orthologues:

Tubulin Alpha-1a Chain

Ensembl ID : ENSAMXG00000004471
Gene Symbol: LOC103046666
2 Cross references
192 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSAMXG00000006726
Gene Symbol: TUBB1
1 Cross references
184 Possible Orthologues:

Tubulin Beta 2a Class Iia

Ensembl ID : ENSAMXG00000032445
Gene Symbol: TUBB2A
4 Cross references
301 Possible Orthologues:

Type-2 Angiotensin Ii Receptor-Like

Ensembl ID : ENSAMXG00000025756
Gene Symbol: LOC103035052
3 Cross references
145 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).